Floating Button
Home News China

‘Hangzhou Six’ tech startup BrainCo is said to file for Hong Kong IPO

Julia Fioretti / Bloomberg
Julia Fioretti / Bloomberg • 2 min read
‘Hangzhou Six’ tech startup BrainCo is said to file for Hong Kong IPO
BrainCo, founded in 2015 by Han Bicheng, develops bionic limbs and non-invasive technologies for human brains
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

(Jan 12): BrainCo has filed confidentially for a Hong Kong initial public offering, according to people familiar with the matter, putting it on track to be the first of China’s so-called Hangzhou Six to trade publicly.

BrainCo is working with China International Capital Corp and UBS Group AG on the share sale, the people said, asking not to be identified because the information is private. It could raise several hundred million dollars, they said.

Deliberations are ongoing and details such as the size of the offering are under discussion, the people said.

Representatives for BrainCo and UBS declined to comment. CICC didn’t respond to a request for comment.

The Hangzhou Six is a group of celebrated next-generation firms from the eastern Chinese city, including DeepSeek. Hangzhou is also home to Alibaba Group Holding Ltd. BrainCo is one of a number of Chinese startups hoping to take on US companies like Neuralink Corp, which have led the industry with state-of-the-art procedures implanting chips into patients’ brains.

Brain-computer interface technology has emerged as a new front in the rivalry between Beijing and Washington, with China throwing its weight behind efforts to develop homegrown champions.

See also: Meituan, Alibaba shares jump as China seeks to curb price wars

BrainCo, founded in 2015 by Han Bicheng, develops bionic limbs and non-invasive technologies for human brains. Unlike Neuralink, it doesn’t use implants.

Shanghai Securities News reported last week that BrainCo completed a two billion yuan financing round co-led by Hong Kong-based private equity firm IDG Capital and Walden International, founded by Intel Corp CEO Lip-Bu Tan.

Other Chinese companies making advances in brain technology include Shanghai StairMed Technology Co, which performs surgery similar to Neuralink’s, and Shanghai NeuroXess Technology.

See also: Chinese consumer price rebound masks deflationary risk ahead

China’s brain-computer interface industry is expected to grow at an annual rate of 20% over the coming years, according to CCID Consulting Co.

Uploaded by Arion Yeow

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.